Castle Creek Biosciences
Castle Creek is a Pennsylvania-based biotechnology company that develops and commercializes gene therapies for the treatment of skin, connective tissue and metabolic diseases.
Business Model:
Revenue: $1M
Employees: 11-50
Industries / Tags:
Detailed Castle Creek Biosciences Information
Geographic Data
Address: 405 Eagleview Boulevard
City: Exton
State: PA
Zip: 19341
Country: US
Financial Info
Stage:
series unknown
Raised Last:
$113M
Raised Total:$225M
Social
Metrics
3,251,334Website Global Rank
4,781Website Monthly Traffic
Twitter Followers
Description
Castle Creek is a Pennsylvania-based biotechnology company that develops and commercializes gene therapies for the treatment of skin, connective tissue and metabolic diseases.
Contact Phone:
+14847136000
Contact Email:
Castle Creek Biosciences went public on the NASDAQ
Listed Exchange:
NASDAQ
Ticker Symbol:
CCBS
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2020 | Debt Financing | 1 | $20M |
Horizon Technology Finance Horizon Technology Finance |
10/2021 | Grant | 1 | $1.8M |
U.S. Food and Drug Administration U.S. Food and Drug Administration |
10/2018 | Venture Round | 2 | $71.8M |
Fidelity Management and Research Company Valor Equity Partners Fidelity Management and Research Company Valor Equity Partners |
10/2016 | Venture Round | 1 | $48M |
Fidelity Management and Research Company Fidelity Management and Research Company |
5/2022 | Venture Round | 3 | $112.8M |
Fidelity Management and Research Company Paragon Biosciences Valor Equity Partners Fidelity Management and Research Company Paragon Biosciences Valor Equity Partners |
3/2020 | Venture Round | 3 | $55M |
Fidelity Management and Research Company Paragon Biosciences Valor Equity Partners Fidelity Management and Research Company Paragon Biosciences Valor Equity Partners |
6/2021 | Debt | $25M |
Valor Equity Partners Paragon Biosciences |
1/2022 | Debt | $11.8M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 1/2022 | Cytotheryx | |
| 9/2019 | Fibrocell Science |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
